John Koo, MD

Director of the Psoriasis, Phototherapy and Skin Treatment Clinic

Dr. John Koo is the director of the Psoriasis, Phototherapy and Skin Treatment Clinic. His main interest is in psoriasis therapy, phototherapy, eczema psychodermatology and quality of life research. He is on the editorial board for the Journal of the American Academy of Dermatology.


Psoriasis and Skin Treatment Center
515 Spruce St.
San Francisco, CA 94118
Phone: (415) 476-4701
Fax: (415) 502-4126

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

More about John Koo

Additional Languages



Harvard University School of Medicine 1981


UCLA Medical Center, Psychiatry 1985
UCSF Medical Center, Dermatology 1988

Selected Research and Publications

  1. Yang EJ, Sekhon S, Beck KM, Bhutani T, Koo J. Neuromodulation in Inflammatory Skin Disease. Dermatol Ther (Heidelb). 2018 Mar; 8(1):1-4.
  2. Jeon C, Nakamura M, Koo J. Examining specimens brought in by a patient with delusional parasitosis. J Am Acad Dermatol. 2018 Jan; 78(1):e1.
  3. Jeon C, Nakamura M, Koo J. The demand for skin biopsy from a patient with delusional parasitosis. J Am Acad Dermatol. 2017 11; 77(5):e125.
  4. Lebwohl MG, Papp KA, Marangell LB, Koo J, Blauvelt A, Gooderham M, Wu JJ, Rastogi S, Harris S, Pillai R, Israel RJ. Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials. J Am Acad Dermatol. 2018 Jan; 78(1):81-89.e5.
  5. Sekhon S, Jeon C, Nakamura M, Koo J. Delusional parasitosis secondary to severe iron deficiency anemia. JAAD Case Rep. 2017 Sep; 3(5):390-391.
  6. Abrouk M, Farahnik B, Zhu TH, Nakamura M, Singh R, Lee K, Lucking SM, Blossom J, Liao W, Koo J, Bhutani T, Shinkai K, Nguyen T. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017 07; 77(1):177-180.
  7. Nakamura M, Abrouk M, Zhu H, Farahnik B, Koo J, Bhutani T. Update on the Systemic Risks of Superpotent Topical Steroids. J Drugs Dermatol. 2017 Jul 01; 16(7):643-648.
  8. Afifi L, Danesh MJ, Lee KM, Beroukhim K, Farahnik B, Ahn RS, Yan D, Singh RK, Nakamura M, Koo J, Liao W. Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey. Dermatol Ther (Heidelb). 2017 Jun; 7(2):227-242.
  9. Menter A, Gold LS, Koo J, Villumsen J, RosÚn M, Lebwohl M. Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled Studies. Skinmed. 2017; 15(2):119-124.
  10. Abrouk M, Beroukhim K, Nakamura M, Zhu TH, Farahnik B, Singh R, Lee K, Koo J, Bhutani T. Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule. Int J Womens Dermatol. 2017 Mar; 3(1 Suppl):S67-S69.
  11. Nakamura M, Koo J. Personality disorders and the "difficult" dermatology patient: Maximizing patient satisfaction. Clin Dermatol. 2017 May - Jun; 35(3):312-318.
  12. Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability. Psoriasis (Auckl). 2016; 6:165-173.
  13. Malakouti M, Brown GE, Leon A, Wang E, Naegeli AN, Edson-Heredia E, Levin E, Koo JYM. The dermatologic intimacy scale: quantitatively measuring the impact of skin disease on intimacy. J Dermatolog Treat. 2017 Jun; 28(4):347-352.
  14. Nakamura M, Koo J. Drug-Induced Tactile Hallucinations Beyond Recreational Drugs. Am J Clin Dermatol. 2016 Dec; 17(6):643-652.
  15. Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS. From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017 Feb; 76(2):290-298.
  16. Farahnik B, Beroukhim K, Danesh M, Nakamura M, Abrouk M, Zhu TH, Singh R, Lee K, Bhutani T, Koo J. Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study. J Am Acad Dermatol. 2016 Nov; 75(5):1068-1071.
  17. Zhu TH, Nakamura M, Farahnik B, Abrouk M, Reichenberg J, Bhutani T, Koo J. Obsessive-compulsive skin disorders: a novel classification based on degree of insight. J Dermatolog Treat. 2017 Jun; 28(4):342-346.
  18. Nguyen CM, Beroukhim K, Danesh MJ, Babikian A, Koo J, Leon A. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016; 9:383-392.
  19. Nakamura M, Lee K, Singh R, Zhu TH, Farahnik B, Abrouk M, Koo J, Bhutani T. Eczema as an adverse effect of anti-TNFa therapy in psoriasis and other Th1-mediated diseases: a review. J Dermatolog Treat. 2017 May; 28(3):237-241.
  20. Nakamura M, Koo J, Bhutani T. Uremic pruritus treated successfully with the Goeckerman Program. Dermatol Online J. 2016 Aug 15; 22(8).

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.